Elena A. Govorkova, MD, PhD
Laboratory Director and leading member of the Center of Excellence for Influenza Research and Surveillance in the Department of Infectious Diseases at St. Jude Children's Research Hospital, Memphis, TN, USA.
Scopus h-index — 46
Web of Science h-index — 44
SCOPUS AuthorID, ORCID, Mendeley, RSCI, ResearchGate
Biography
EDUCATION:
1985 Ph.D., The D.I. Ivanovsky Institute of Virology, Russian Academy of Medical Sciences, Moscow, Russia Major: Virology
1980 M.D., I. M. Sechenov Moscow Medical Academy, Moscow, Russia Diploma with Honors
PROFESSIONAL EXPERIENCE:
2009 — present Laboratory Director, Division of Virology, Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN, USA
2006–2009 Scientific Manager, Division of Virology, Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN, USA
2003–2006 Staff Scientist, Division of Virology, Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN, USA
2000–2003 Visiting Professor, Department of Virology and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1996–2000 Senior Research Scientist, D.I. Ivanovsky Institute of Virology, Moscow, Russia
1993–1996 Visiting Professor, Department of Virology and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1988–1993 Senior Research Scientist, D.I. Ivanovsky Institute of Virology, Moscow, Russia
1984–1988 Junior Research Scientist, D.I. Ivanovsky Institute of Virology, Moscow, Russia
Research interests and main scientific achievements
Dr. Govorkova's research interests are primarily focused on the control of influenza infection. Her studies on the cell-derived influenza vaccines provided important information on the alternative host systems for cultivation of viruses and vaccine production. Her work since 2000 has involved evaluation of anti-influenza drugs against seasonal and highly pathogenic influenza viruses on enzymatic and cellular levels, as well as in the animal models. Her studies are focused on the advantages/disadvantages of combinations of antiviral drugs that target different viral proteins and have different mechanisms of action on the reduction of influenza virus replication in vitro, protection in animals and emergence of resistant variants. She is the author of over 135 original research publications and review papers in peer-reviewed journals, in addition to patents and awards. Dr. Govorkova is a member of a number of professional societies and is actively sharing her expertise to mentor and train young scientists.
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.